Tisdag 31 Mars | 23:52:41 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-01-20 08:00 Bokslutskommuniké 2026
2026-10-15 08:00 Kvartalsrapport 2026-Q3
2026-07-09 08:00 Kvartalsrapport 2026-Q2
2026-04-15 08:00 Kvartalsrapport 2026-Q1
2026-03-27 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2026-03-26 - Årsstämma
2026-01-21 - Bokslutskommuniké 2025
2025-12-29 - Extra Bolagsstämma 2026
2025-10-22 - Kvartalsrapport 2025-Q3
2025-07-31 - Kvartalsrapport 2025-Q2
2025-05-15 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2025-05-14 - Årsstämma
2025-04-16 - Kvartalsrapport 2025-Q1
2025-01-22 - Bokslutskommuniké 2024
2024-10-16 - Kvartalsrapport 2024-Q3
2024-07-17 - Kvartalsrapport 2024-Q2
2024-07-12 - Split FLERIE 100:1
2024-05-14 - Årsstämma
2024-05-08 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2024-04-15 - Kvartalsrapport 2024-Q1
2024-01-24 - Bokslutskommuniké 2023
2023-11-28 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-05-24 - Årsstämma
2023-05-24 - Kvartalsrapport 2023-Q1
2023-05-08 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2023-02-23 - Bokslutskommuniké 2022
2022-11-23 - Kvartalsrapport 2022-Q3
2022-08-26 - Kvartalsrapport 2022-Q2
2022-06-02 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2022-06-01 - Årsstämma
2022-05-16 - Kvartalsrapport 2022-Q1
2022-02-23 - Bokslutskommuniké 2021
2021-11-24 - Kvartalsrapport 2021-Q3
2021-08-25 - Kvartalsrapport 2021-Q2
2021-06-04 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2021-06-03 - Årsstämma
2021-05-05 - Kvartalsrapport 2021-Q1
2021-02-25 - Bokslutskommuniké 2020
2021-01-12 - Extra Bolagsstämma 2020
2020-11-25 - Kvartalsrapport 2020-Q3
2020-08-26 - Kvartalsrapport 2020-Q2
2020-05-07 - Kvartalsrapport 2020-Q1
2020-04-21 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2020-04-20 - Årsstämma
2020-02-20 - Bokslutskommuniké 2019
2019-11-27 - Kvartalsrapport 2019-Q3
2019-10-09 - Extra Bolagsstämma 2019
2019-08-15 - Kvartalsrapport 2019-Q2
2019-05-07 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2019-05-06 - Årsstämma
2019-05-06 - Kvartalsrapport 2019-Q1
2019-02-20 - Bokslutskommuniké 2018
2018-11-19 - Kvartalsrapport 2018-Q3
2018-08-28 - Kvartalsrapport 2018-Q2
2018-05-25 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2018-05-24 - Årsstämma
2018-05-17 - Kvartalsrapport 2018-Q1
2018-02-26 - Bokslutskommuniké 2017
2017-11-17 - Kvartalsrapport 2017-Q3
2017-08-25 - Kvartalsrapport 2017-Q2
2017-05-31 - X-dag ordinarie utdelning FLERIE 0.00 SEK
2017-05-30 - Årsstämma
2017-05-30 - Kvartalsrapport 2017-Q1
2017-02-27 - Bokslutskommuniké 2016
2016-11-22 - Kvartalsrapport 2016-Q3

Beskrivning

LandSverige
ListaMid Cap Stockholm
SektorHälsovård
IndustriBioteknik
Flerie är en aktiv långsiktig life science-investerare med fokus på bioteknik- och läkemedelsinvesteringar globalt. Bolaget är baserat i Stockholm och London, och förvaltar en portfölj med investeringar i Europa, Israel och USA. Huvudfokus ligger på att förse organisationer som främst verkar inom läkemedelsutveckling, med tjänster och resurser. Flerie grundades 2011 och har sitt huvudkontor i Stockholm.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-03-26 10:15:00

The Annual General Meeting of Flerie AB (publ) reg. no. 559067-6820 (the “Company”) has been held on 26 March 2026 and in particular the following resolutions were made.

Adoption of the annual report and the auditor’s report

The Annual General Meeting resolved to approve the profit and loss statement and the balance sheet regarding the parent Company and the Group, appropriation of the profit in accordance with the Board of Directors proposal and not to distribute any dividends for the financial year 2025, as well as to discharge the CEO and Board members from liability.

Election of Board members and Chairman of the Board of Directors

As members of the Board of Directors it was resolved, in accordance with the proposal of the Nomination Committee, to re-elect Thomas Eldered, Cecilia Edström, Anders Ekblom and Jenni Nordborg, and to elect Holger Kissel as a new board member. Thomas Eldered was re-elected as the Chairman of the Board of Directors. It was resolved that the total remuneration for the Board of Directors (including remuneration for work in the Board's committees as set out below) shall amount to SEK 1,570,000 of which SEK 400,000 shall be paid to the Chairman of the Board of Directors and SEK 275,000 shall be paid to each of the other members of the Board. In addition, a remuneration of SEK 50,000 shall be paid to the Chairman of the Audit Committee, and a fee of SEK 20,000 shall be paid to the Chairman of the Remuneration Committee.

Election of auditor

The Annual General Meeting resolved, in accordance with the proposal of the Nomination Committee, to re-elect Ernst & Young AB as auditor for the period until the end of the next Annual General Meeting with Jennifer Rock-Baley as auditor in charge. The fees shall be paid in accordance with approved invoices.

Adoption of guidelines for remuneration to senior executives and approval of the remuneration report

The Annual General Meeting resolved, in accordance with the proposal of the Board of Directors, to adopt guidelines for remuneration to senior executives to remain in effect until further notice and to and to approve the remuneration report.

Adoption of principles for the appointment of and instructions for the Nomination Committee

The Annual General Meeting resolved, in accordance with the proposal of the Nomination Committee, to adopt principles for the appointment of and instructions for the Nomination Committee. The principles shall apply until the general meeting decides otherwise.

Authorisation for the Board of Directors to resolve on issues of shares, warrants and/or convertible bonds

The Annual General Meeting resolved unanimously, in accordance with the proposal of the Board of Directors, to authorise the Board of Directors to, on one or several occasions during the period until the next Annual General Meeting, with or without deviation from the shareholders’ preferential rights, resolve on issues of shares, warrants and/or convertible bonds that comprise the issue of or conversion to ordinary shares corresponding to a dilution of a maximum of 10 percent of the share capital and the voting rights in the Company after dilution, based on the number of shares in the Company at the time of the Annual General Meeting. Payment for subscribed shares and/or convertible bonds shall be made in cash, in kind or by way of set-off.

Resolution on bonus issue with issue of new ordinary shares

The Annual General Meeting resolved unanimously, in accordance with the proposal of the Board of Directors, to increase the Company’s share capital by SEK 23,172,704 through a bonus issue of 11,586,352 ordinary shares. The increase amount shall be obtained by transferring SEK 23,172,704 from non-restricted equity in accordance with the adopted balance sheet in the annual report for 2025. The Board of Directors was authorized to determine the final number of shares and the increase amount based on the actual number of outstanding shares in the Company as of the record date on 18 May 2026. The following conditions shall apply to the bonus issue. Each existing ordinary share on the record date for the bonus issue shall entitle to one (1) bonus share right. Seven (7) bonus share rights entitle the holder to one (1) new ordinary share. Any surplus bonus rights that do not correspond to whole bonus shares shall be sold by arrangement of the Company in accordance with Chapter 11, Section 9 of the Swedish Companies Act (2005:551). The sale shall be executed by a securities institution, and the proceeds of the sale shall accrue to the shareholders concerned. The new ordinary shares shall entitle to dividends for the first time on the record date for dividends that occurs immediately after the bonus issue has been registered with the Swedish Companies Registration Office.

Resolution on the termination of the share redemption programme and amendment of the Articles of Association

The Annual General Meeting resolved unanimously, in accordance with the proposal of the Board of Directors, to amend the Articles of Association in order to establish that the redemption programme shall be carried out for the final time in 2026.